PharmGKB (@pharmgkb) 's Twitter Profile
PharmGKB

@pharmgkb

PharmGKB's aim is to aid researchers in understanding how genetic variation among individuals contributes to differences in reactions to drugs.

ID: 236171835

linkhttp://www.pharmgkb.org/ calendar_today10-01-2011 00:03:20

938 Tweet

1,1K Followers

76 Following

PharmGKB (@pharmgkb) 's Twitter Profile Photo

Our #warfarin PD pathway has been updated to include newly discovered candidate genes. Check it out pharmgkb.org/pathway/PA1450… #pharmacogenomics

PharmGKB (@pharmgkb) 's Twitter Profile Photo

This release includes new pathways for ribavirin PK & Prednisone and Prednisolone PK created as part of a collaboration between PharmGKB & reactome! More at our blog pharmgkb.blogspot.com/2022/09/pharmg… #pharmacogenomics #pharmacology

PharmVar (@pharmvar) 's Twitter Profile Photo

#NAT2 is coming to #PharmVar! Are you an expert for this gene? We are seeking volunteers for our expert panel. Please contact [email protected] if you are interested

PharmGKB (@pharmgkb) 's Twitter Profile Photo

We've just released new site walkthrough and #pharmacogenomics tutorial videos on our YouTube channel youtube.com/channel/UCnYHY… Learn more at our blog pharmgkb.blogspot.com/2022/09/new-tu… #PGx #training #TwitteRx

We've just released new site walkthrough and #pharmacogenomics tutorial videos on our YouTube channel youtube.com/channel/UCnYHY… Learn more at our blog pharmgkb.blogspot.com/2022/09/new-tu… #PGx #training #TwitteRx
reactome (@reactome) 's Twitter Profile Photo

Announcing a Reactome and @PharmGKB collaboration on pharmacokinetic and ADME pathways, including Prednisone and Ribavirin ADME pathways released in V82. More in our news: reactome.org/about/news/179…. #ADME #pathways #pharmacogenomics #collaboration

Announcing a Reactome and @PharmGKB collaboration on pharmacokinetic and ADME pathways, including Prednisone and Ribavirin ADME pathways released in V82. More in our news: reactome.org/about/news/179…. 
#ADME #pathways #pharmacogenomics  #collaboration
The Journal of Molecular Diagnostics (@jmdiagn) 's Twitter Profile Photo

"TPMT and NUDT15 Genotyping Recommendations" a new collaborative project from Association for Molecular Pathology, CPIC, CAPathologists, PharmGKB, and the European Society for #pgx and Personalized Therapy. Recommendations are FREE online: jmdjournal.org/article/S1525-…

Simran Maggo (@simranpgx) 's Twitter Profile Photo

Great team effort - now to do more! Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples frontiersin.org/articles/10.33… #pgx #pharmacogenomics #pharmacy #PGX PharmGKB #cyp2d6 #nanopore

PharmGKB (@pharmgkb) 's Twitter Profile Photo

PharmCAT v2.0 is out! Lots of updates including the addition of new CPIC guidelines and guidance from the Dutch Pharmacogenomics Working Group (DPWG). pharmcat.org Read the blogpost describing updates at pharmgkb.blogspot.com/2022/10/pharmc… #pharmcat #pharmacogenomics

PharmCAT v2.0 is out! Lots of updates including the addition of new CPIC guidelines and guidance from the Dutch Pharmacogenomics Working Group (DPWG). pharmcat.org Read the blogpost describing updates at pharmgkb.blogspot.com/2022/10/pharmc… #pharmcat #pharmacogenomics
GlobalBiodata (@globalbiodata) 's Twitter Profile Photo

GBC today announces the first set of Global Core Biodata Resources (GCBRs) - a collection of 37 data resources whose long-term funding and sustainability is critical to the global research endeavour in life sciences and biomedicine. See globalbiodata.org/global-biodata… #opendata

GBC today announces the first set of Global Core Biodata Resources (GCBRs) - a collection of 37 data resources whose long-term funding and sustainability is critical to the global research endeavour in life sciences and biomedicine. See globalbiodata.org/global-biodata…  #opendata
PharmGKB (@pharmgkb) 's Twitter Profile Photo

If you have PGx experience, please take ClinGen PGx Working Group's survey: stanforduniversity.qualtrics.com/jfe/form/SV_bK… Goal: solicit feedback about criteria and terminology to define clinical validity and actionability for PGx genes and variants. Takes about 10 min & open until the end of Feb!

If you have PGx experience, please take ClinGen PGx Working Group's survey: stanforduniversity.qualtrics.com/jfe/form/SV_bK… 
Goal: solicit feedback about criteria and terminology to define clinical validity and actionability for PGx genes and variants. Takes about 10 min & open until the end of Feb!
ClinGen (@clingenresource) 's Twitter Profile Photo

The ClinGen Pharmacogenomics Working Group survey closes this Friday, June 30 - If you haven’t already, please share your thoughts with us at stanforduniversity.qualtrics.com/jfe/form/SV_1I…

The ClinGen Pharmacogenomics Working Group survey closes this Friday, June 30 - If you haven’t already, please share your thoughts with us at stanforduniversity.qualtrics.com/jfe/form/SV_1I…
PharmGKB (@pharmgkb) 's Twitter Profile Photo

If your institution tests for DPYD variants before fluoropyrimidine chemotherapy, please take this brief survey. It will be used to develop best practice guidelines for pre-treatment DPYD testing. umich.qualtrics.com/jfe/form/SV_9F…

PharmGKB (@pharmgkb) 's Twitter Profile Photo

5 days left for early registration to the CPIC meeting (now being called ClinPGx 2024)! eventbrite.com/e/clinpgx-2024… Also, book your hotel through upenn.app.box.com/s/bodll2c8v21r…

Dr. Marylyn D. Ritchie, PhD (@marylynritchie) 's Twitter Profile Photo

Excited to host the #CLINPGX2024 meeting with Penn IBI PharmGKB and CPIC. We have an exciting meeting planned for the next two days. Thanks to all who traveled to Penn Medicine for the meeting to discuss clinical implementation of pharmacogenomics.

Excited to host the #CLINPGX2024  meeting with <a href="/UPennIBI/">Penn IBI</a> <a href="/pharmgkb/">PharmGKB</a> and <a href="/cpicpgx/">CPIC</a>. We have an exciting meeting planned for the next two days. Thanks to all who traveled to <a href="/PennMedicine/">Penn Medicine</a> for the meeting to discuss clinical implementation of pharmacogenomics.